Knockdown of FLOT1 has been shown to significantly impair cell proliferation and tumourigenicity of breast and esophageal squamous cell carcinoma cells in vitro and in vivo through the Akt/FOXO3a pathways46, 47. This evidence concerns the gene FLOT1 and esophageal squamous cell carcinoma.